FindTrial
Sign In

To study whether Remdesivir (an antiviral, used for the treatment of COVID - 19) is effective in COVID 19 patients with respect to complications of the disease or death.

To Study the impact of Remdesivir on complications and mortality of COVID 19 patients admitted in tertiary care hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/01/030385
Enrollment
1066
Registered
2021-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patient admitted in Kasturba Hospital, Manipal with COVID-19 positive by RTPCR / RAT between April 2020 and October 2020 2. All patient categorized as moderate or severe COVID as per standard guidelines.

Exclusion criteria

Exclusion criteria: 1. Patients who have sepsis from other sources 2. Patients with underlying lung disease like COPD, ILD, destroyed lung which may contribute to their hypoxia . 3. Patients with malignancy and other causes of immune suppression. 4. Patients who are pregnant.

Design outcomes

Primary

MeasureTime frame
The impact of remdesivir on outcomes in these patients will be analyzedTimepoint: On admission, during the hospital stay till discharge of the patient—

Secondary

MeasureTime frame
Comorbidities Details of hospital stay Need for Oxygen and mechanical ventilationTimepoint: during the hospital stay on daily basis—

Countries

India

Contacts

Public ContactDr Sneha S

Kasturba Medical College, MAHE, Manipal

sneha.s@manipal.edu9741970110

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026